Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical practice guidelines for the care of psychologically distressed bereaved families who have lost members to physical illness including cancer.
Akechi T, Kubota Y, Ohtake Y, Setou N, Fujimori M, Takeuchi E, Kurata A, Okamura M, Hasuo H, Sakamoto R, Miyamoto S, Asai M, Shinozaki K, Onishi H, Shinomiya T, Okuyama T, Sakaguchi Y, Matsuoka H. Akechi T, et al. Among authors: ohtake y. Jpn J Clin Oncol. 2022 May 31;52(6):650-653. doi: 10.1093/jjco/hyac025. Jpn J Clin Oncol. 2022. PMID: 35253040 Free PMC article.
Incidence of carnitine deficiency in patients with cancer pain: A pilot study.
Sakai K, Matsuoka H, Ohtake Y, Makimura C, Izumi H, Fujita Y, Otsuka M, Tsurutani J, Nishio K, Nakagawa K, Koyama A. Sakai K, et al. Among authors: ohtake y. Mol Clin Oncol. 2017 Mar;6(3):331-333. doi: 10.3892/mco.2017.1159. Epub 2017 Feb 7. Mol Clin Oncol. 2017. PMID: 28451408 Free PMC article.
Avoiding diagnostic errors in psychosomatic medicine: a case series study.
Koyama A, Ohtake Y, Yasuda K, Sakai K, Sakamoto R, Matsuoka H, Okumi H, Yasuda T. Koyama A, et al. Among authors: ohtake y. Biopsychosoc Med. 2018 Mar 13;12:4. doi: 10.1186/s13030-018-0122-3. eCollection 2018. Biopsychosoc Med. 2018. PMID: 29563965 Free PMC article.
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Matsuoka H, Iwase S, Miyaji T, Kawaguchi T, Ariyoshi K, Oyamada S, Satomi E, Ishiki H, Hasuo H, Sakuma H, Tokoro A, Shinomiya T, Otani H, Ohtake Y, Tsukuura H, Matsumoto Y, Hasegawa Y, Kataoka Y, Otsuka M, Sakai K, Matsuda Y, Morita T, Koyama A, Yamaguchi T. Matsuoka H, et al. Among authors: ohtake y. J Pain Symptom Manage. 2019 Oct;58(4):645-653. doi: 10.1016/j.jpainsymman.2019.06.020. Epub 2019 Jun 26. J Pain Symptom Manage. 2019. PMID: 31254640 Free article. Clinical Trial.
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Matsuoka H, Iwase S, Miyaji T, Kawaguchi T, Ariyoshi K, Oyamada S, Satomi E, Ishiki H, Hasuo H, Sakuma H, Tokoro A, Matsuda Y, Tahara K, Otani H, Ohtake Y, Tsukuura H, Matsumoto Y, Hasegawa Y, Kataoka Y, Otsuka M, Sakai K, Nakura M, Morita T, Yamaguchi T, Koyama A. Matsuoka H, et al. Among authors: ohtake y. Support Care Cancer. 2020 Jun;28(6):2931-2939. doi: 10.1007/s00520-019-05138-9. Epub 2019 Nov 25. Support Care Cancer. 2020. PMID: 31761974 Clinical Trial.
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
Matsuoka H, Tsurutani J, Chiba Y, Fujita Y, Sakai K, Yoshida T, Nakura M, Sakamoto R, Makimura C, Ohtake Y, Tanaka K, Hayashi H, Takeda M, Okuno T, Takegawa N, Haratani K, Koyama A, Nishio K, Nakagawa K. Matsuoka H, et al. Among authors: ohtake y. Oncologist. 2023 Mar 17;28(3):278-e166. doi: 10.1093/oncolo/oyac233. Oncologist. 2023. PMID: 36426809 Free PMC article. Clinical Trial.
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.
Fujita Y, Matsuoka H, Chiba Y, Tsurutani J, Yoshida T, Sakai K, Nakura M, Sakamoto R, Makimura C, Ohtake Y, Tanaka K, Hayashi H, Takeda M, Okuno T, Takegawa N, Haratani K, Takahama T, Tanizaki J, Koyama A, Nishio K, Nakagawa K. Fujita Y, et al. Among authors: ohtake y. Oncol Lett. 2023 Jul 4;26(2):355. doi: 10.3892/ol.2023.13941. eCollection 2023 Aug. Oncol Lett. 2023. PMID: 37545623 Free PMC article.
Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.
Fujita Y, Matsuoka H, Chiba Y, Tsurutani J, Yoshida T, Sakai K, Nakura M, Sakamoto R, Makimura C, Ohtake Y, Tanaka K, Hayashi H, Takahama T, Tanizaki J, Koyama A, Nishio K, Nakagawa K. Fujita Y, et al. Among authors: ohtake y. Mol Clin Oncol. 2024 Nov 29;22(2):14. doi: 10.3892/mco.2024.2809. eCollection 2025 Feb. Mol Clin Oncol. 2024. PMID: 39720462 Free PMC article.
271 results